{"id":"W3202510981","doi":"10.1136/annrheumdis-2021-220920","title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Placebo; Internal medicine; Clinical endpoint; Rituximab; Lupus nephritis; CD20; Gastroenterology; Surgery; Clinical trial; Lymphoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002525163,0.001730375,0.004387037,0.0005441069,0.0005369216,0.001405891,0.001060306,0.003127257,0.006311481],"category_scores_gemma":[0.003434178,0.0006784329,0.002042186,0.0005994836,0.00148638,0.001028911,0.0004371288,0.002075116,0.0007851233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007730677,"about_ca_system_score_gemma":0.001104376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008732604,"about_ca_topic_score_gemma":0.001461391,"domain_scores_codex":[0.9985132,0.000894856,0.0001289107,0.0002130967,0.0001048933,0.0001450386],"domain_scores_gemma":[0.9986656,0.0005000828,0.000384131,0.00008145989,0.00008915054,0.0002795633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9890633,0.001306438,0.0001447047,0.001488282,0.0006628428,0.00002789679,0.00003036434,0.00009256021,0.0008866847,0.00006370233,0.0002609853,0.005972219],"study_design_scores_gemma":[0.988364,0.01055987,0.0002796338,0.00006228398,0.0002343413,0.00001442719,0.000007009066,0.00008308623,0.00009349255,0.00004864709,0.0002481469,0.000004958729],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9472639,0.03339475,0.001400329,0.001376006,0.002247829,0.009945325,0.001248732,0.0002270232,0.002896165],"genre_scores_gemma":[0.9705595,0.01021118,0.002160172,0.001483763,0.001256406,0.01037142,0.0006672901,0.00002652559,0.003263796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006311481,"threshold_uncertainty_score":0.02111399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05956355332456594,"score_gpt":0.3332283862371711,"score_spread":0.2736648329126052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}